Arthur-quan M. Tran

Oncology | Obstetrics and Gynecology

710 Lawrence Expy
3rd Floor Dept 390
Santa Clara, CA 95051

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer.

Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer.

Journal: Frontiers in pharmacology

Published: October 07, 2024

Vulvar cancer survival by primary treatment modality: A retrospective cohort study.

Vulvar cancer survival by primary treatment modality: A retrospective cohort study.

Journal: Gynecologic oncology

Published: April 21, 2023

Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer.

Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer.

Journal: Frontiers in oncology

Published: March 30, 2021

SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer.

SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer.

Journal: Frontiers in oncology

Published: October 31, 2020

Treatment of invasive Paget's disease of the vulva in pregnancy: A case report.

Treatment of invasive Paget's disease of the vulva in pregnancy: A case report.

Journal: Gynecologic oncology reports

Published: April 16, 2020

ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitro.

ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitro.

Journal: American journal of cancer research

Published: June 25, 2018

Economic Analysis of Neoadjuvant Chemotherapy Versus Primary Debulking Surgery for Advanced Epithelial Ovarian Cancer Using an Aggressive Surgical Paradigm.

Economic Analysis of Neoadjuvant Chemotherapy Versus Primary Debulking Surgery for Advanced Epithelial Ovarian Cancer Using an Aggressive Surgical Paradigm.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 24, 2018

Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.

Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.

Journal: American journal of cancer research

Published: April 10, 2018

Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cells.

Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cells.

Journal: American journal of translational research

Published: January 05, 2018

Impact of Trainee Involvement in Cervical Excision Procedures: Does Trainee Involvement Impact Quality?

Impact of Trainee Involvement in Cervical Excision Procedures: Does Trainee Involvement Impact Quality?

Journal: Journal of lower genital tract disease

Published: December 23, 2017

Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.

Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.

Journal: American journal of cancer research

Published: November 06, 2017

Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase.

Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase.

Journal: Gynecologic oncology

Published: September 21, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026